It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
The mecA gene is commonly used to identify resistance in Staphylococcus aureus, but historically is not used for coagulase-negative staphylococci (CoNS). Analysis of 412 staphylococcal blood cultures (2014–2018) revealed that the absence of mecA had high concordance (100%) with oxacillin susceptibility for S. aureus and CoNS alike.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details

1 Section of Pediatric Infectious Diseases, Children’s Hospital Colorado and the University of Colorado School of Medicine, Aurora, Colorado, USA
2 Section of Pediatric Infectious Diseases, Children’s Hospital Colorado and the University of Colorado School of Medicine, Aurora, Colorado, USA; Department of Pathology and Laboratory Medicine, Children’s Hospital Colorado, Aurora, Colorado, USA; Department of Infection Control and Epidemiology, Children’s Hospital Colorado, Aurora, Colorado, USA
3 Department of Pathology and Laboratory Medicine, Children’s Hospital Colorado, Aurora, Colorado, USA; Clinical Science, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA
4 Department of Pathology and Laboratory Medicine, Children’s Hospital Colorado, Aurora, Colorado, USA
5 Section of Pediatric Infectious Diseases, Children’s Hospital Colorado and the University of Colorado School of Medicine, Aurora, Colorado, USA; Department of Infection Control and Epidemiology, Children’s Hospital Colorado, Aurora, Colorado, USA